Dr. Weinberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 800-789-7366Fax+1 215-349-5915
Education & Training
- Rockefeller UniversityMS, Clinical Investigation, 2016
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2009 - 2012
- University of Maryland School of MedicineClass of 2009
- University of MarylandMD, 2009
- Princeton UniversityAB, 2003
Certifications & Licensure
- PA State Medical License 2016 - 2024
- NY State Medical License 2011 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA) Start of enrollment: 2023 May 23
- LiveSMART Trial to Prevent Falls in Patients With Cirrhosis Start of enrollment: 2023 Jun 13
- FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study Start of enrollment: 2022 Dec 15
Publications & Presentations
PubMed
- 2 citationsA Tailored Virtual Program for Alcohol Use Disorder Treatment Among Liver Transplant Candidates and Recipients Is Feasible and Associated With Lower Post-Transplant Re...Arpita Goswami, Ethan Weinberg, Lynda Coraluzzi, Therese Bittermann, Jonathan Nahas
Clinical Transplantation. 2024-07-01 - 52 citationsPCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis.Norihiro Yamaguchi, Ethan M. Weinberg, Alexander Nguyen, Maria V. Liberti, Hani Goodarzi
Elife. 2019-12-16 - 29 citationsRBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon.Johnny Yu, Albertas Navickas, Hosseinali Asgharian, Bruce Culbertson, Lisa Fish
Cancer Discovery. 2020-06-08
Press Mentions
- PharmaIN to Present Promising Interim Data from Its Ongoing Phase 1 Trial of PHIN-214, an Optimized Vasopressor for Decompensated Cirrhosis, at the Liver Meeting® 2024October 16th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: